Last reviewed · How we verify

NCT03374059

Exercise and Life Modification for Text-Neck

Completed NA Last updated 15 December 2017
What this trial tests

NA trial testing Exercise program in Pain in 85 participants. Completed in 1 September 2017.

Timeline
1 September 2016
Primary endpoint
1 September 2017
1 September 2017

Quick facts

Lead sponsorBaskent University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment85
Start date1 September 2016
Primary completion1 September 2017
Estimated completion1 September 2017
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Baskent University

Who can join

Adults 18 to 30, any sex, with Pain or Exercise. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objectives: The purpose of the study was to investigate the effects of exercise and life modification on pain and disability in "text neck". Methods: Eighty-five participants were randomly divided into three groups: Exercise (n=29), Exercise+Life modification (n=28), and Control Group (n = 28). Pain intensity during rest, activity, and at night was evaluated with Visual Analogue Scale (VAS) and functional assessment was done by using Neck Disability Index at the beginning and at the end of 4 weeks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Exercise program

Trials testing the same drug.

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Baskent University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03374059.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing